These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 575477)

  • 21. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
    Stalder M; Hauert J; Bachmann F
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1462-4. PubMed ID: 6606226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
    Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P
    Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
    Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM
    J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter: Fibrinolytic activity in the endometrial adenocarcinoma.
    Parrilla JJ; Aznar J; Estelles A
    Thromb Diath Haemorrh; 1975 Dec; 34(3):864-6. PubMed ID: 1239829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J; Chordá C; Montes R; Páramo JA
    Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis.
    Carr ME; Krishnamurti C; Alving BM
    Thromb Haemost; 1992 Jan; 67(1):106-10. PubMed ID: 1615464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tissue plasminogen activator activity in early prostatic cancer and in bone metastases of prostatic cancer].
    Pflüger H; Kirchheimer J; Ritschl P; Köller A; Hienert G; Binder BR
    Wien Klin Wochenschr; 1984 Sep; 96(17):658-61. PubMed ID: 6083673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.
    Loskutoff DJ; Edgington TE
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3903-7. PubMed ID: 143664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of temperature on the release of plasminogen activator.
    Fracasso JF; Rodrigues LA; Yashuda Y
    Braz J Med Biol Res; 1988; 21(1):31-3. PubMed ID: 3179575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasminogen activators and their physiological role].
    Andreenko GV
    Ukr Biokhim Zh (1978); 1983; 55(3):329-43. PubMed ID: 6346623
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.
    Loskutoff DJ; van Mourik JA; Erickson LA; Lawrence D
    Proc Natl Acad Sci U S A; 1983 May; 80(10):2956-60. PubMed ID: 6574465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of fibrin on arterial endothelial cells in vitro--an electron microscopic study.
    Okadome K; Kinjo M; Tanaka K
    Acta Pathol Jpn; 1981 May; 31(3):413-21. PubMed ID: 7196674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hypophysectomy on the tissue and blood plasminogen activator activity in the rat.
    Smokovitis A; Hattey E; Binder BR
    Haemostasis; 1985; 15(2):151-6. PubMed ID: 3159631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Simultaneous study of the activities of prothrombin, factor X, antihemophilic globulin, thromhin time, fibrin polymerization time and thromybocyte count in the right heart, aorta, renal vein, portal vein and inferior vena cava of the rabbit].
    Schimpf K; Hansen B; Meier J
    Klin Wochenschr; 1968 Mar; 46(6):332-3. PubMed ID: 5682014
    [No Abstract]   [Full Text] [Related]  

  • 38. FIBRIONLYTIC ACTIVITY OF VASCULAR ENDOTHELIUM.
    WARREN BA
    Br Med Bull; 1964 Sep; 20():213-4. PubMed ID: 14216085
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulation of plasminogen activator activity in the endothelium. Influence of local factors.
    Risberg B
    Bibl Anat; 1979; (18):114-5. PubMed ID: 496807
    [No Abstract]   [Full Text] [Related]  

  • 40. Regions of constantly increased plasminogen activator activity along the intima of the normal aorta.
    Smokovitis A
    Haemostasis; 1978; 7(5):303-19. PubMed ID: 151002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.